Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


IMPAC Medical Systems and The Mattson Jack Group Announce Expanded Agreement

    Licensing Agreement Will Facilitate In-Depth Market Analysis of Cancer
                                  Treatment

    MOUNTAIN VIEW, Calif., May 14 /PRNewswire/ -- IMPAC Medical Systems, Inc.,
part of the Elekta Group and a leading provider of information technology
solutions for oncology care, and The Mattson Jack Group (MJG), a world leader
in healthcare consulting services, today announce an expanded licensing
agreement that will grant MJG access to IMPAC's oncology-specific electronic
medical record (EMR) for point of care data, in addition to data from its
National Oncology DataBase(TM) (NODB), to be used in MJG's Patient Metrics
module of Cancer!MPact.
    Like the NODB, the EMR data is provided from participating IMPAC
customers. The new de-identified EMR-derived dataset has the potential for
adding a unique and expanded body of information from hundreds of thousands of
cancer cases in near real time. When added to data from the more than
2 million NODB cancer registry derived cases, it greatly augments the breadth
and depth of the resultant information.
    Bill Mattson, Co-chairman and Co-CEO of the Mattson Jack Group, said, "We
are pleased to expand our ongoing relationship with IMPAC. This agreement will
facilitate research and analyses on geographical trends. The longitudinal EMR
point of care data will be invaluable in providing more timely information on
actual treatment practice at the point of care."
    "IMPAC and The Mattson Jack Group have a long history of working together.
We are pleased to expand our agreement so that retrospective analysis and
research into treatment practices and outcomes can be taken to the next
level," said Joseph K. Jachinowski, IMPAC president and CEO.
    Demonstrations of IMPAC's oncology-specific EMR will be available at
IMPAC's booth # 2872 during the annual meeting of the American Society of
Clinical Oncology (ASCO) in Orlando, Florida, May 14-16, 2005.

     For more information, please contact:
     Julie DeSantis, Public Relations Manager
     IMPAC Medical Systems, Inc.
     Tel:  650-623-8883, e-mail:  jdesantis@impac.com

     Investor Enquiries:
     International:  Peter Ejemyr, Group VP Corporate Communications,
       Elekta AB
     Tel:  +46 733 611 000, e-mail:  peter.ejemyr@elekta.com

     United States: Lars Jonsteg, VP Investor Relations North America,
       Elekta Inc.
     Tel:  +46 708-783 735, e-mail:  lars.jonsteg@elekta.com

    About IMPAC Medical Systems
    IMPAC Medical Systems, Inc., a company in the Elekta Group, provides
healthcare IT solutions that streamline clinical and business operations
across the spectrum of cancer care. IMPAC's open integration to multiple
healthcare data and imaging systems offers oncology-specific patient charting
and practice management, as well as best-of-breed systems for anatomic
pathology, clinical laboratory, and cancer registry. With products that range
from diagnosis and treatment through long-term follow-up, IMPAC provides a
comprehensive oncology management solution that helps improve overall
communication, process efficiency, and quality patient care. For more
information about IMPAC's products or services, please call 888-GO-IMPAC or
visit http://www.impac.com.

    About Elekta
    Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for
improved cancer care and management of brain disorders. All of Elekta's
solutions employ non-invasive or minimally invasive techniques and are
therefore clinically effective, gentle on the patient and cost-effective.
    With approx. 1700 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta's products or
services, please visit http://www.elekta.com.

    About the Mattson Jack Group
    Formed in 1986, MJG focuses its talent in three areas of core competency:
Business Analytics, Brand Optimization and Corporate Development Services in
the pharmaceutical and biotech markets. Its ongoing mission is to "Accelerate
Client Growth through advanced analysis, planning, decision support, and
implementation." MJG consultants have expertise in pricing and reimbursement,
custom epidemiology, technology assessment, business and strategic plan
development, due-diligence and licensing support, market modeling and
forecasting, and primary market research. The Mattson Jack Group is a member
of the Kantar Division of WPP Company, a $6.5 billion global communications
services firm. For more information, please visit http://www.mattsonjack.com.


SOURCE IMPAC Medical Systems, Inc.




Back to Topback to top

Related links:
  • http://www.impac.com
    CONTACT:
    Julie DeSantis, Public Relations Manager of
    IMPAC Medical Systems, Inc., +1-650-623-8883, or
    jdesantis@impac.com; or investors, International, Peter Ejemyr,
    Group VP Corporate Communications of Elekta AB, +46 733 611 000,
    or peter.ejemyr@elekta.com, or United States, Lars Jonsteg, VP
    Investor Relations North America, of Elekta Inc., +46 708-783
    735, or lars.jonsteg@elekta.com